Long COVID causes persistent symptoms affecting numerous individuals. Enoxaparin, a low-molecular-weight heparin, may alleviate these symptoms by thinning blood, reducing microclots, enhancing oxygen delivery, and combating inflammation. Early studies suggest potential benefits for patients with vascular dysfunction, although more extensive clinical trials are necessary to confirm effectiveness and safety.
Tag: microclots
Role of Galectin-3 in Long COVID Symptoms
Prof. Resia Pretorius and Dr. Douglas Kell's research reveals why long COVID can induce blood clotting issues, focusing on abnormal clots and the protein galectin-3. Their findings suggest potential treatments, such as targeting galectin-3 and repurposing amyloid therapies, while emphasizing the need for further study on long COVID's implications for millions affected.